Regulatory Role of IL6 in Immune-Related Adverse Events during Checkpoint Inhibitor Treatment in Melanoma

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Correlation of interleukin 6 and transforming growth factor β1 with peripheral blood regulatory T cells in rheumatoid arthritis patients: a potential biomarker2018 · 9 citations
2. 2Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma2007 · 84 citations
3. 3Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis2021 · 325 citations
4. 4Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update2021 · 2,223 citations
5. 5Insights into effect of the Asp25/Asp25ʹ protonation states on binding of inhibitors Amprenavir and MKP97 to HIV-1 protease using molecular dynamics simulations and MM-GBSA calculations2021 · 5 citations